Case Study: Syndicated Patient Study

Original respiratory illness market intelligence generated for leading pharmas

  • Very recently LiveContact fielded one of the largest and most comprehensive respiratory illness studies ever conducted in Canada.
  • The syndicated online study gathered responses from 1000 patients throughout Canada with asthma, COPD and nasal allergies and included both adults and children.
  • Five major pharmas competing in these categories subscribed to the study and each subscribing client was invited to submit questions.
  • In the end the study included more than 130 multi-pathway questions generating powerful, "never-seen-before" market intelligence.
  • Subscribing clients have expressed that their modest investment in this study will provide them with key marketing advantages in these highly competitive categories while saving tens of thousands of dollars versus custom research.

IMPORTANT NOTE: This study is still available for purchase. For more information please contact us at research@livecontact.com.

Back to top

 

Case Study: Online Patient Omnibus

Enhanced market intelligence through collaboration

  • Very recently LiveContact fielded one of the largest and most comprehensive omnibus studies in a multi-billion dollar category in which both Rx and OTC pharmas compete.
  • The online omnibus study gathered responses from 1000 patients throughout Canada with various types of these related diseases.
  • Member clients - major Rx and OTC pharmas competing in the category - subscribed to the study and submitted questions.
  • In the end the study results included 1300 pages of tables generating powerful, "never-seen-before" market intelligence.
  • Subscribing clients agree the value delivered was exceptional and that their investment in the study will provide them with key marketing advantages while saving tens of thousands of dollars versus custom research.

Back to top

 

Case Study: Proprietary Patient Panel

Differentiation achieved with accelerated study

  • Subsequent to negative publicity related to competitive products, our client - a top-5 Canadian pharma with a leading lipid metabolism regulator, needed to conduct time-sensitive research with hundreds of patients using only their product.
  • Despite the product’s relatively small market share, by using our patient panel with more than 14,000 high cholesterol patients, we were able to quickly assemble a panel of patients for whom the product had been prescribed.
  • Within 2 days of receiving the approved questionnaire the first in-depth patient interviews were conducted and the study was completed well ahead of schedule.
  • Our client was able to use the information to differentiate their product from the category and successfully set their product apart from the negative publicity.

Back to top

 

Case Study: Ultra-Low Incidence Patient Research

Top pharma achieves marketing advantage via rare disease study

  • Recently a top 10 pharma needed to conduct a patient insight study with sufferers of an extremely rare genetic disease affecting fewer than 1 in 40,000 Canadians.
  • The study was required to provide patient needs analysis and determine the impact of a new competitive product entry.
  • As specialist physicians managing patients with the disease are no longer willing to solicit patients for marketing research studies (citing privacy and legal concerns) the patients had to be recruited directly.
  • Through our patient registry www.CanadianHealthSurveys.ca, working directly with the related patient advocacy group and other web recruitment methods, LiveContact successfully assembled one of the largest consenting, per-capita panels of these patients in the world.
  • Our client has subsequently conducted several additional studies with the panel and enjoys a significant advantage in market intelligence versus its competitors.

Back to top

 

Case Study: Physician Research

Marketing giant optimises sales force deployment

  • A leading sales force deployment consultancy challenged us to conduct profiling research amongst specialist physicians. Their client, a specialty division of one of the world’s healthcare giants, needed to properly align its sales territories to achieve the most efficient physician coverage with its modest-size sales force.
  • Our client had employed a number of other research companies to execute this study in the past, but was hoping to achieve better results through a higher survey completion rate without increasing costs.
  • The client’s telephone survey was the most complex one we had seen. It included several complex algorithms, response paths and multivariate analysis.
  • It was essential for us to maximize survey completions and ensure absolute accuracy of the responses as the results would be used to deploy a very expensive team of sales representatives.
  • The survey was to be conducted amongst a sample of 2600 specialist offices. Our client typically achieved a 20% completion rate amongst this audience in past surveys and challenged us to improve on this rate.
  • With significant attention to survey design, programming, and most importantly, training, we achieved 785 (30%) completions.
  • The survey results played a key role in the alignment of a valuable sales team.

Back to top